We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZM icon
476
Zoom
ZM
$27.1B
$6.06M 0.02%
86,682
-10,858
-11% -$754K
CHTR icon
477
Charter Communications
CHTR
$16.9B
$6.02M 0.02%
13,682
+7,259
+113% +$3.02M
KRTX
478
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.99M 0.02%
35,415
-126
-0.4% -$23.7K
PVH icon
479
PVH
PVH
$4.01B
$5.94M 0.02%
77,600
+2,300
+3% +$190K
EME icon
480
Emcor
EME
$35.7B
$5.83M 0.02%
27,700
-12,900
-32% -$2.7M
PRI icon
481
Primerica
PRI
$10.1B
$5.82M 0.02%
30,000
-300
-1% -$61.4K
MDRX
482
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.78M 0.02%
440,225
-2,800
-0.6% -$36.7K
DOCU
483
DocuSign
DOCU
$10.4B
$5.76M 0.02%
137,050
+40,296
+42% +$1.98M
XRX icon
484
Xerox
XRX
$456M
$5.68M 0.02%
361,700
+331,300
+1,090% +$5.23M
MAR icon
485
Marriott International
MAR
$99B
$5.63M 0.02%
28,633
+11,329
+65% +$2.25M
RMD icon
486
ResMed
RMD
$30.3B
$5.6M 0.02%
37,868
+16,274
+75% +$2.94M
CRWD icon
487
CrowdStrike
CRWD
$189B
$5.56M 0.02%
132,920
+6,636
+5% +$258K
CROX icon
488
Crocs
CROX
$6.14B
$5.54M 0.02%
62,800
+30,300
+93% +$3.11M
ELF icon
489
e.l.f. Beauty
ELF
$4.85B
$5.46M 0.02%
49,700
-8,400
-14% -$1.02M
PRTA icon
490
Prothena Corp
PRTA
$440M
$5.45M 0.02%
112,913
-403
-0.4% -$23.9K
ENSG icon
491
The Ensign Group
ENSG
$10.4B
$5.44M 0.02%
58,500
-2,300
-4% -$218K
CM icon
492
Canadian Imperial Bank of Commerce
CM
$108B
$5.42M 0.02%
140,432
-65,000
-32% -$2.68M
KMI icon
493
Kinder Morgan
KMI
$70.5B
$5.38M 0.02%
324,529
-7,937
-2% -$137K
BN icon
494
Brookfield
BN
$103B
$5.29M 0.02%
253,940
+125
+0% +$2.82K
CUBE icon
495
CubeSmart
CUBE
$9.34B
$5.28M 0.02%
138,582
+44,178
+47% +$1.86M
MSA icon
496
Mine Safety
MSA
$6.73B
$5.28M 0.02%
33,465
-9,737
-23% -$1.67M
BLD
497
DELISTED
TopBuild
BLD
$5.23M 0.02%
20,800
-1,400
-6% -$386K
QRVO icon
498
Qorvo
QRVO
$8.01B
$5.22M 0.02%
54,697
+2
+0% +$204
BR icon
499
Broadridge
BR
$17.9B
$5.21M 0.02%
29,125
+11,214
+63% +$1.99M
INST
500
DELISTED
Instructure Holdings, Inc.
INST
$5.21M 0.02%
205,000

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.